Bonetti et al., 1989 - Google Patents
Co-infection with human immunodeficiency virus-type 1 (HIV-1) and cytomegalovirus in two intravenous drug usersBonetti et al., 1989
View PDF- Document ID
- 3281709447162975378
- Author
- Bonetti A
- Weber R
- Vogt M
- Wunderli W
- Siegenthaler W
- Lüthy R
- Publication year
- Publication venue
- Annals of internal medicine
External Links
Snippet
A mononucleosis-like illness is frequently recognized retrospectively as the first manifestation of infection with human immunodeficiency virus-type 1 (HIV-1). This acute but transient retroviral syndrome may include symptoms such as malaise, fever, sweats …
- 208000005721 HIV Infections 0 title abstract description 58
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—AIDS or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Brun-Vezinet et al. | Prevalence of antibodies to lymphadenopathy-associated retrovirus in African patients with AIDS | |
| Scharschmidt et al. | Hepatitis B in patients with HIV infection: relationship to AIDS and patient survival | |
| Dorsett et al. | Anti-lymphocyte antibodies in patients with the acquired immune deficiency syndrome | |
| Marlink et al. | Clinical, hematologic, and immunologic cross-sectional evaluation of individuals exposed to human immunodeficiency virus type-2 (HIV-2) | |
| Cheingsong-Popov et al. | Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain | |
| Sumaya et al. | Enhanced serological and virological findings of Epstein-Barr virus in patients with AIDS and AIDS-related complex | |
| Bonetti et al. | Co-infection with human immunodeficiency virus-type 1 (HIV-1) and cytomegalovirus in two intravenous drug users | |
| Hollander | Cerebrospinal fluid normalities and abnormalities in individuals infected with human immunodeficiency virus | |
| Hayashi et al. | Prevalence of hepatitis C virus antibodies among patients infected with human immunodeficiency virus | |
| Singh et al. | Hepatitis B, C and human immunodeficiency virus infections in multiply-injected kala-azar patients in Delhi | |
| Resnick et al. | Detection of HTLV-III/LAV-specific IgG and antigen in bronchoalveolar lavage fluid from two patients with lymphocytic interstitial pneumonitis associated with AIDS-related complex | |
| CAO et al. | Antibodies to human immunodeficiency virus type 1 in the urine specimens of HIV-1-seropositive individuals | |
| Re et al. | Antibody against human immunodeficiency virus type 1 (HIV-1) Tat protein may have influenced the progression of AIDS in HIV-1-infected hemophiliac patients | |
| Grose et al. | Guillain-Barré syndrome following administration of live measles vaccine | |
| Tindall et al. | Primary human immunodeficiency virus infection: clinical and serologic aspects | |
| Mergener et al. | Immunoglobulin class-and subclass-specific HIV antibody detection in serum and CSF specimens by ELISA and Western blot | |
| JPH01503487A (en) | Method for detecting antibodies against human immunodeficiency virus | |
| Handsfield et al. | Screening and diagnostic performance of enzyme immunoassay for antibody to lymphadenopathy-associated virus | |
| TORSETH et al. | Recombinant HIV structural proteins detect specific cellular immunity in vitro in infected individuals | |
| PROBER et al. | MEDICAL MANAGEMENT OF NEWBORNS AND INFANTS BORN OF HUMAN IMMUNODEFIEICNCY VIRUS-SEROPOSITIVE MOTHERS | |
| Chalmers et al. | Cerebrospinal fluid and human immunodeficiency virus: findings in healthy, asymptomatic, seropositive men | |
| Groopman | Clinical spectrum of HTLV-III in humans | |
| Süttmann et al. | Cytomegalovirus infection in HIV-1-infected individuals | |
| Gaines | Primary HIV infection: clinical and diagnostic aspects | |
| Blomberg et al. | HTLV-I and-II in intravenous drug users from Sweden and Denmark |